Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine 2% eye drops to improve trabeculectomy outcomes in glaucoma
IRCT138706111154N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in Glaucoma, sponsored by Mashhad University of Medical Sciences. Started Sep 2013; status: completed.
02
Drugs
cyclosporine
03
Conditions
Glaucoma
Beyond the preview
Go deeper on IRCT138706111154N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138706111154N1.